
    
      The investigator study compare the effect of lipid lowering agent on the enhancement of
      visual acuity and on reduction of macular edema in patients with diabetic retinopathy and
      also compare their effect on reduction of cardiovascular risk on diabetic patients via
      assessment of ASCVD risk score
    
  